Treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC) with EGFR T790M and other sensitizing mutations.
| Brand Name: | Furmonertinib Tablets |
| Generic Name: | Furmonertinib Tablets |
| Strength: | • Oral Tablets: 40 mg x 28 tablets/box |
| Manufacturer: | |
| Approved By: | NMPA |
Source Details: Patient Information
Access Furmonertinib for NSCLC on a Named Patient Import Basis
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to Furmonertinib Tabletsn for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).
For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.
